Therapy Finder Advisors*

David Fisher MD PhD
David E Fisher MD PhD
Department of Dermatology
Harvard Medical School
Keith Flaherty MD
Keith T Flaherty MD
Department of
Medicine
Harvard Medical School
See All Advisors

Learn the Science Behind This Tool

Science and the Melanoma Molecular Disease Model
collabrx logo

Therapy Finder – Professional

Provide Information About Your Patient's Melanoma

Melanoma Stage
Stage 0, I, II
Advanced Stage
Primary Origin
* Required field
Metastatic Sites
(Selectable for Stage IV disease)
Molecular Information
BRAF
NRAS
C-KIT
GNAQ
GNA11

How to Use This Tool

  1. Provide tumor information
  2. Learn about molecular tests, targeted therapies and clinical trials
  3. Discuss information presented here with patient

Learn More

Drugs in the News**
GSK2118436

antibodies attacking a cancer

Investigational drug, GSK2118436 (dabrafenib), reported to provide superior clinical benefit in combination with the MEK inhibitor, trametinib

Other Drugs in the News
#